Does Transcatheter Laser Myocardial Revascularization Have a Potential Role in the Treatment of Patients with Refractory Angina Who Are Not Considered Candidates for PTCA or CABG?
Ran Kornowski, M.D.
and Martin B. Leon, M.D.
Drs. Kornowski and Leon are from the Cardiology Research Foundation, Washington Hospital Center, Washington, DC, USA.
Drs. Kornowski and Leon report no commercial conflict of interest.
Estimated time to complete:
Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Upon completion of this Cyberounds®
, you should be able to:
- Understand the theoretical basis for the benefit achieved by creating laser cut channels in ischemic myocardium
- Discuss both the surgical approaches and percutaneous approaches to TMR
- Understand the criteria for determining potential patient candidates for TMR trials.